About: Rezistence/sensitivita in vitro u pacientek s karcinomem ovaria     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • The highest frequency of resistance in vitro occured for etoposid, gemcitabin and paclitaxel and the most effective chemotherapeutical agents were cisplatinum and topotecan. Cisplatin had the lowest incidence of drug resistance in vitro than carboplatin. (en)
  • Nejvyšší rezistenci in vitro pomocí MTT testu jsme zjistili u gemcitabinu, etoposidu a paklitaxelu a nejnižší rezistenci u cisplatiny a topotekanu. Karboplatina vykazovala rezistenci častěji než cisplatina.
  • Nejvyšší rezistenci in vitro pomocí MTT testu jsme zjistili u gemcitabinu, etoposidu a paklitaxelu a nejnižší rezistenci u cisplatiny a topotekanu. Karboplatina vykazovala rezistenci častěji než cisplatina. (cs)
Title
  • Rezistence/sensitivita in vitro u pacientek s karcinomem ovaria
  • Rezistence/sensitivita in vitro u pacientek s karcinomem ovaria (cs)
  • Resistance/sensitivity in vitro in ovarian cancer patients (en)
skos:prefLabel
  • Rezistence/sensitivita in vitro u pacientek s karcinomem ovaria
  • Rezistence/sensitivita in vitro u pacientek s karcinomem ovaria (cs)
  • Resistance/sensitivity in vitro in ovarian cancer patients (en)
skos:notation
  • RIV/00216208:11150/10:10079137!RIV11-MZ0-11150___
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • P(NS9737)
http://linked.open...iv/cisloPeriodika
  • 3
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 285233
http://linked.open...ai/riv/idVysledku
  • RIV/00216208:11150/10:10079137
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • MTT assay; chemotherapeutic agent; sensitivity; resistance; ovarian cancer (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • CZ - Česká republika
http://linked.open...ontrolniKodProRIV
  • [C1C21524E87A]
http://linked.open...i/riv/nazevZdroje
  • Ceska Gynekologie
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...vavai/riv/projekt
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 75
http://linked.open...iv/tvurceVysledku
  • Brigulová, Kateřina
  • Sedláková, Iva
  • Tošner, Jindřich
  • Červinka, Miroslav
  • Řezáč, Adam
  • Škapinec, Peter
  • Špaček, Jiří
  • Tomšová, Markéta
issn
  • 1210-7832
number of pages
http://localhost/t...ganizacniJednotka
  • 11150
is http://linked.open...avai/riv/vysledek of
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 77 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software